Patent Application
Utility
App. No. 18/381,817
· Confirmation No. 7776
SUBSTITUTED TETRACYCLINE COMPOUNDS FOR TREATMENT OF INFLAMMATORY SKIN DISORDERS
Inventors:
Haregewein Assefa, Beena Bhatia, Michael P. Draper, Laura Honeyman, Oak K. Kim, Dennis P. Molnar
Applicant:
Paratek Pharmaceuticals, Inc.
Abandoned -- Incomplete Application (Pre-examination)
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2024-06-07 | ABN |
Abandonment | 2 | View | |
| 2024-06-03 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2024-06-03 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2024-06-03 | XT/ |
Extension of Time | 1 | View | |
| 2024-05-29 | OATH |
Oath or Declaration filed | 7 | View | |
| 2023-11-03 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2023-11-03 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2023-11-03 | NTC.MISS.PRT |
Notice to File Missing Parts | 3 | View | |
| 2023-11-03 | WELCOME.LET |
Welcome Letter from USPTO Director and Deputy Director | 1 | View | |
| 2023-10-19 | TRNA |
Transmittal of New Application | 1 | View | |
| 2023-10-19 | DRW |
Drawings-only black and white line drawings | 1 | View | |
| 2023-10-19 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2023-10-19 | ADS |
Application Data Sheet | 11 | View | |
| 2023-10-19 | SPEC |
Specification | 78 | View | |
| 2023-10-19 | CLM |
Claims | 22 | View | |
| 2023-10-19 | ABST |
Abstract | 1 | View | |
| 2023-10-19 | A.PE |
Preliminary Amendment | 1 | View | |
| 2023-10-19 | SPEC |
Specification | 1 | View | |
| 2023-10-19 | CLM |
Claims | 3 | View | |
| 2023-10-19 | REM |
Applicant Arguments/Remarks Made in an Amendment | 1 | View |
Inventors
Haregewein Assefa
Braintree, MA
Beena Bhatia
Mansfield, MA
Michael P. Draper
Windham, NH
Laura Honeyman
Etobicoke, CANADA
Oak K. Kim
Cambridge, MA
Dennis P. Molnar
Hopkinton, MA
Attorneys & Agents of Record
Prosecution
- Customer No.
- 86738
- Docket No.
- 124418-29115
- Confirmation No.
- 7776
Parent
is a Continuation of
→
App. 18/111,209
Filed 2023-02-17
· Abandoned -- Incomplete Application (Pre-examination)
Parent
is a Continuation of
→
App. 17/856,019
Filed 2022-07-01
· Abandoned -- Incomplete Application (Pre-examination)
Parent
is a Continuation of
→
App. 17/527,472
Filed 2021-11-16
· Abandoned -- Incomplete Application (Pre-examination)
Parent
is a Continuation of
→
App. 17/226,166
Filed 2021-04-09
· Abandoned -- Incomplete Application (Pre-examination)
Parent
is a Continuation of
→
App. 17/004,852
Filed 2020-08-27
· Abandoned -- Incomplete Application (Pre-examination)
Parent
is a Continuation of
→
App. 16/722,042
Filed 2019-12-20
· Abandoned -- Incomplete Application (Pre-examination)
Parent
is a Continuation of
→
App. 16/407,228
Filed 2019-05-09
· Abandoned -- Incomplete Application (Pre-examination)
Parent
is a Continuation of
→
App. 16/115,733
Filed 2018-08-29
· Abandoned -- Incomplete Application (Pre-examination)
Parent
is a Continuation of
→
App. 15/859,968
Filed 2018-01-02
· Abandoned -- Incomplete Application (Pre-examination)
Parent
is a Continuation of
→
App. 15/598,590
Filed 2017-05-18
· Abandoned -- Incomplete Application (Pre-examination)
Parent
is a Continuation of
→
App. 15/284,758
Filed 2016-10-04
· Expressly Abandoned -- During Examination
Parent
is a Continuation of
→
App. 13/987,655
· US 9,481,639
Filed 2013-08-19
· Patented Case
Parent
is a Continuation of
→
App. 11/963,509
· US 8,513,223
Filed 2007-12-21
· Patented Case
Parent
Claims priority from a provisional application
→
App. 60/876,434
Filed 2006-12-21
· Provisional Application Expired
Child
is a Continuation of
→
App. 19/061,400
Filed 2025-02-24
· Docketed New Case - Ready for Examination
No recorded assignments were found for this patent.
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 18/381,817
- Filed
- 2023-10-19
External Links